A liver transplant becomes necessary when the liver is too damaged to sustain life and cannot recover on its own. This happens through two broad paths: chronic disease that destroys the liver over months or years, or sudden catastrophic failure that leaves days or weeks to act. About 9,000 liver transplants are performed in the United States each year, and the outcomes are strong, with a one-year survival rate of 92% and a five-year survival rate above 81%.
Chronic Liver Disease: The Most Common Path
Most people who need a liver transplant arrive there after years of progressive damage. The liver is resilient and can function even when significantly scarred, which means chronic disease often advances silently before symptoms appear. By the time a transplant is discussed, the liver has typically reached cirrhosis, a stage where scar tissue has replaced so much healthy tissue that the organ can no longer keep up with the body’s needs.
Several conditions cause this slow accumulation of damage:
- Fatty liver disease (MASH) is now the fastest-growing reason people are added to the transplant waiting list. It starts with fat buildup in the liver, progresses to inflammation, and eventually leads to cirrhosis. It’s closely tied to obesity, type 2 diabetes, and metabolic syndrome.
- Alcohol-related liver disease results from years of heavy drinking that inflames and scars liver tissue. In severe cases, a single episode of alcohol-related hepatitis can push an already-damaged liver past the point of recovery.
- Chronic hepatitis B and C are viral infections that cause ongoing liver inflammation. Hepatitis C was once a leading reason for transplants, though effective antiviral treatments have reduced those numbers significantly.
- Autoimmune liver diseases occur when the immune system mistakenly attacks liver tissue. In primary biliary cholangitis, for example, the immune system damages bile ducts inside the liver. Bile leaks out, triggers inflammation, and causes progressive scarring that eventually leads to cirrhosis and liver failure.
Liver Cancer
Liver cancer, specifically hepatocellular carcinoma, is another major reason for transplantation. Because most liver cancers develop in livers already damaged by cirrhosis, a transplant can treat both the cancer and the underlying disease at once. Not everyone with liver cancer qualifies, though. Eligibility follows strict guidelines known as the Milan Criteria: a single tumor no larger than 5 centimeters, or up to three tumors each no larger than 3 centimeters, with no cancer spread to blood vessels or other organs. These limits exist because transplant outcomes are best when the cancer is caught relatively early.
Acute Liver Failure
Some people need a transplant not because of years of disease, but because their liver fails suddenly. Acute liver failure is far less common than chronic disease, but it’s a medical emergency. The liver deteriorates over days or weeks in someone who previously had no liver problems.
Acetaminophen (Tylenol) overdose is the most common cause of acute liver failure in the United States, responsible for about half of all cases and roughly 20% of emergency liver transplants. What’s striking is that intentional overdoses and accidental ones, where someone takes too much over several days without realizing it, account for equal numbers of cases. Once acute liver failure sets in, about 28% of patients die and a third require a transplant. Other triggers include reactions to prescription medications, herbal supplements, certain viral infections, and rare conditions like Wilson’s disease or autoimmune hepatitis that present suddenly.
When the Liver Can No Longer Compensate
A damaged liver doesn’t fail all at once. For a long time, the remaining healthy tissue picks up the slack. Doctors call this “compensated” cirrhosis, and many people live for years in this stage without major symptoms. The turning point comes when complications begin stacking up, a shift called “decompensation.” This is typically when transplant conversations start.
The complications that signal a liver in serious trouble include:
- Fluid buildup in the abdomen (ascites) that requires repeated drainage or no longer responds to diuretics.
- Internal bleeding from swollen veins in the esophagus or stomach, caused by rising pressure in the blood vessels around the liver. Uncontrolled bleeding from these veins is a life-threatening emergency.
- Hepatic encephalopathy, a condition where toxins the liver normally filters begin affecting the brain. Early signs include trouble concentrating, memory lapses, and slowed reactions. As it worsens, personality changes, confusion, sleep disruption, and eventually coma can follow. Once someone develops noticeable encephalopathy, median survival without a transplant drops to about two years.
- Severe jaundice, the yellowing of skin and eyes that signals the liver can no longer process bilirubin, a waste product from old red blood cells.
How Patients Are Prioritized
Donor livers are scarce, so a scoring system determines who receives one first. In the U.S., this is the MELD-Na score (Model for End-Stage Liver Disease, adjusted for sodium levels). It ranges from 6 to 40 and is calculated from three blood test results that reflect how well the liver and kidneys are functioning and how well the blood is clotting.
A higher score means more urgent need. People with scores of 15 or above generally have better outcomes with a transplant than without one, making that a rough threshold for when transplantation becomes the better option compared to continuing medical management. The score is recalculated regularly, so as liver function declines, a patient moves up the list.
Alcohol-Related Disease and Eligibility
For years, transplant centers required six months of sobriety before listing someone with alcohol-related liver disease. That rule is changing. Research has shown that some patients with severe alcohol-related hepatitis who are too sick to survive the waiting period can have excellent outcomes with earlier transplantation, provided they meet strict criteria: it must be their first episode of liver decompensation, they need a strong support system, they cannot have untreated psychiatric conditions, and they must show genuine commitment to lifelong abstinence.
Transplant teams now use standardized tools to assess relapse risk rather than relying on a single sobriety clock. Factors that raise concern include a history of multiple failed rehab attempts, very high prior alcohol intake (more than 10 drinks daily), untreated mental health conditions, use of other substances, and weak social support. Blood tests can now detect alcohol consumption up to a month after drinking, adding an objective layer to the evaluation.
Children and Liver Transplants
Children need liver transplants for different reasons than adults. The most common is biliary atresia, a condition present at birth where the bile ducts inside or outside the liver are blocked or absent. It accounts for at least half of all pediatric liver transplants. Without functioning bile ducts, bile accumulates in the liver and causes rapid scarring. Surgery in the first weeks of life can sometimes restore bile flow, but many children eventually need a transplant as the damage progresses. Other pediatric causes include inherited metabolic disorders where the liver lacks enzymes needed to process certain substances, leading to toxic buildup.
What Survival Looks Like After Transplant
Liver transplant outcomes have improved substantially over the past two decades. Based on data from the Scientific Registry of Transplant Recipients, adult recipients now have a 92.2% survival rate at one year, 81.4% at five years, and 64.1% at ten years. The highest risk period is the first six months, when the body is most likely to reject the new organ. After that initial window, long-term survival is strong, though recipients take immunosuppressive medications for life to prevent rejection.
Living-donor transplants, where a healthy person donates a portion of their liver, have expanded the donor pool. The liver is one of the few organs that can regenerate; both the donor’s remaining portion and the transplanted piece grow back to near-normal size within weeks.